These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21952832)

  • 1. Significant association between common polymorphisms in the aromatase gene CYP19A1 and bone mineral density in postmenopausal women.
    Mullin BH; Carter KW; Lewis JR; Ingley E; Wilson SG; Prince RL
    Calcif Tissue Int; 2011 Dec; 89(6):464-71. PubMed ID: 21952832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: the GOOD study.
    Lorentzon M; Swanson C; Eriksson AL; Mellström D; Ohlsson C
    J Bone Miner Res; 2006 Feb; 21(2):332-9. PubMed ID: 16418790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density.
    Ezura Y; Nakajima T; Kajita M; Ishida R; Inoue S; Yoshida H; Suzuki T; Shiraki M; Hosoi T; Orimo H; Emi M
    J Bone Miner Res; 2003 Sep; 18(9):1642-9. PubMed ID: 12968673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women.
    Rojano-Mejía D; Coral-Vázquez RM; Espinosa LC; Romero-Hidalgo S; López-Medina G; García Mdel C; Coronel A; Ibarra R; Canto P
    Maturitas; 2012 Jan; 71(1):49-54. PubMed ID: 22079369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an aromatase haplotype that is associated with gene expression and postmenopausal osteoporosis.
    Riancho JA; Valero C; Naranjo A; Morales DJ; Sañudo C; Zarrabeitia MT
    J Clin Endocrinol Metab; 2007 Feb; 92(2):660-5. PubMed ID: 17118999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Klotho gene polymorphisms are associated with osteocalcin levels but not bone density of aged postmenopausal women.
    Mullin BH; Wilson SG; Islam FM; Calautti M; Dick IM; Devine A; Prince RL
    Calcif Tissue Int; 2005 Sep; 77(3):145-51. PubMed ID: 16151675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
    Mencej-Bedrač S; Preželj J; Marc J
    Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
    Haiman CA; Dossus L; Setiawan VW; Stram DO; Dunning AM; Thomas G; Thun MJ; Albanes D; Altshuler D; Ardanaz E; Boeing H; Buring J; Burtt N; Calle EE; Chanock S; Clavel-Chapelon F; Colditz GA; Cox DG; Feigelson HS; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn JN; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Le Marchand L; Lenner P; Lund E; Panico S; Peeters PH; Pike MC; Riboli E; Tjonneland A; Travis R; Trichopoulos D; Wacholder S; Ziegler RG
    Cancer Res; 2007 Mar; 67(5):1893-7. PubMed ID: 17325027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density.
    Riancho JA; Zarrabeitia MT; Valero C; Sañudo C; Mijares V; González-Macías J
    Eur J Endocrinol; 2006 Jul; 155(1):53-9. PubMed ID: 16793950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the WNT10B gene, bone mineral density, and fractures in postmenopausal women.
    Perez-Castrillon JL; Olmos JM; Nan DN; Castillo J; Arozamena J; Montero A; Perez-Nuñez MI; Riancho JA
    Calcif Tissue Int; 2009 Aug; 85(2):113-8. PubMed ID: 19458884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CYP1A1 and CYP1B1 polymorphisms with bone mineral density variations in postmenopausal Mexican-Mestizo women.
    Chávez B; Vilchis F; Rojano-Mejía D; Coral Vázquez RM; Aguirre-García MDC; Canto P
    Gynecol Endocrinol; 2017 Aug; 33(8):607-610. PubMed ID: 28300467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
    Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
    Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women.
    Wang Q; Chen Z; Huang Y; Li Q; Zhu L; Cai X; He G; Xie Y; Liu Q
    Int Immunopharmacol; 2013 Oct; 17(2):404-7. PubMed ID: 23856613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone and body composition response to testosterone therapy vary according to polymorphisms in the CYP19A1 gene.
    Aguirre LE; Colleluori G; Robbins D; Dorin R; Shah VO; Chen R; Jan IZ; Qualls C; Villareal DT; Armamento-Villareal R
    Endocrine; 2019 Sep; 65(3):692-706. PubMed ID: 31325085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant enzymes GSR, SOD1, SOD2, and CAT gene variants and bone mineral density values in postmenopausal women: a genetic association analysis.
    Mlakar SJ; Osredkar J; Prezelj J; Marc J
    Menopause; 2012 Mar; 19(3):368-76. PubMed ID: 22089180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women.
    Feldman K; Szappanos A; Butz H; Grolmusz V; Majnik J; Likó I; Kriszt B; Lakatos P; Tóth M; Rácz K; Patócs A
    Steroids; 2012 Nov; 77(13):1345-51. PubMed ID: 22986073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women.
    Markatseli AE; Hatzi E; Bouba I; Georgiou I; Challa A; Tigas S; Tsatsoulis A
    Maturitas; 2011 Oct; 70(2):188-93. PubMed ID: 21840657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone.
    Albagha OM; Pettersson U; Stewart A; McGuigan FE; MacDonald HM; Reid DM; Ralston SH
    J Med Genet; 2005 Mar; 42(3):240-6. PubMed ID: 15744038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women.
    Ezura Y; Kajita M; Ishida R; Yoshida S; Yoshida H; Suzuki T; Hosoi T; Inoue S; Shiraki M; Orimo H; Emi M
    J Bone Miner Res; 2004 Aug; 19(8):1296-301. PubMed ID: 15231017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.